LDXHF (Lumos Diagnostics Holdings) NonCurrent Deferred Liabilities : $0.00 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Lumos Diagnostics Holdings NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Lumos Diagnostics Holdings's non-current deferred liabilities for the quarter that ended in Dec. 2024 was $0.00 Mil.

Lumos Diagnostics Holdings NonCurrent Deferred Liabilities Historical Data

The historical data trend for Lumos Diagnostics Holdings's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumos Diagnostics Holdings NonCurrent Deferred Liabilities Chart

Lumos Diagnostics Holdings Annual Data

Trend

Jun22

Jun23

Jun24

NonCurrent Deferred Liabilities

Lumos Diagnostics Holdings Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
NonCurrent Deferred Liabilities	Get a 7-Day Free Trial			-	-	-	-	-

Lumos Diagnostics Holdings NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Lumos Diagnostics Holdings's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Lumos Diagnostics Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lumos Diagnostics Holdings Ltd (OTCPK:LDXHF) » Definitions » NonCurrent Deferred Liabilities

Comparable Companies

Traded in Other Exchanges

LDX:Australia

Address

2724 Loker Avenue West, Carlsbad, CA, USA, 92010

Website

https://www.lumosdiagnostics.com

Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture, and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. The group is dedicated to providing contract research and development services, focusing on the innovation, development, manufacturing, and commercialization of point-of-care diagnostic solutions for both clinical and consumer applications. It generates maximum revenue from commercial services and solutions relating to POC diagnostic tests. The group has one operating segment, which is the provision of point-of-care diagnostics goods and services, and it operates across two geographical regions, the United States and Australia. and the majority of revenue is generated from the United States.

Lumos Diagnostics Holdings Headlines

From GuruFocus

Economic Evaluation of Lumos Diagnostics' FebriDx� Point-of-Care Test Highlights $2.5 Billion in Potential U.S. Healthcare Cost Savings Annually

By Business Wire Business Wire • 10-06-2021

Lumos Diagnostics Raises $63M AUD in ASX IPO

By Business Wire Business Wire • 07-08-2021

Lumos Diagnostics FY21 Full Year Results

By Business Wire Business Wire • 08-31-2021

Lumos Diagnostics Receives Authorization for CoviDx� SARS-CoV-2 Rapid Antigen Test in Canada

By Business Wire Business Wire • 11-03-2021

Dr. Jerome Adams, Former U.S. Surgeon General, Joins Lumos Diagnostics as a Strategic Healthcare Adviser

By Business Wire Business Wire • 09-14-2021